Cargando…
Azithromycin Inhibits Biofilm Formation by Staphylococcus xylosus and Affects Histidine Biosynthesis Pathway
Staphylococcus xylosus, a coagulase-negative, non-pathogenic bacterium, responsible for opportunistic infections in humans and bovine mastitis, has the ability to form biofilms, which are responsible for persistent infections and antibiotic resistance. In our study, azithromycin significantly inhibi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048454/ https://www.ncbi.nlm.nih.gov/pubmed/30042679 http://dx.doi.org/10.3389/fphar.2018.00740 |
_version_ | 1783340113345904640 |
---|---|
author | Ding, Wenya Zhou, Yonghui Qu, Qianwei Cui, Wenqiang God’spower, Bello Onaghise Liu, Yanyan Chen, Xueying Chen, Mo Yang, Yanbei Li, Yanhua |
author_facet | Ding, Wenya Zhou, Yonghui Qu, Qianwei Cui, Wenqiang God’spower, Bello Onaghise Liu, Yanyan Chen, Xueying Chen, Mo Yang, Yanbei Li, Yanhua |
author_sort | Ding, Wenya |
collection | PubMed |
description | Staphylococcus xylosus, a coagulase-negative, non-pathogenic bacterium, responsible for opportunistic infections in humans and bovine mastitis, has the ability to form biofilms, which are responsible for persistent infections and antibiotic resistance. In our study, azithromycin significantly inhibited biofilm formation by altering protein expression. Of the 1764 proteins measured by the isobaric Tag for Relative and Absolute Quantification (iTRAQ) technique, only 148 proteins showed significantly different expression between the azithromycin-treated and untreated cells. Most ribosomal proteins were markedly up-regulated, and the expression of the proteins involved in histidine biosynthesis, which, in turn, influence biofilm formation, was down-regulated, particularly imidazole glycerophosphate dehydratase (IGPD). Previously, we had observed that IGPD plays an important role in biofilm formation by S. xylosus. Therefore, hisB expression was studied by real-time PCR, and the interactions between azithromycin and IGPD were predicted by molecular docking analysis. hisB was found to be significantly down-regulated, and six bond interactions were observed between azithromycin and IGPD. Many active atoms of azithromycin did not interact with the biologically active site of IGPD. Surface plasmon resonance analysis used to further study the relationship between IGPD and azithromycin showed minimum interaction between them. Histidine content in the azithromycin-treated and untreated groups was determined. We noted a slight difference, which was not consistent with the expression of the proteins involved in histidine biosynthesis. Therefore, histidine degradation into glutamate was also studied, and we found that all proteins were down-regulated. This could be the reason why histidine content showed little change between the treated and untreated groups. In summary, we found that azithromycin is a potential inhibitor of S. xylosus biofilm formation, and the underlying mechanism was preliminarily elucidated in this study. |
format | Online Article Text |
id | pubmed-6048454 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60484542018-07-24 Azithromycin Inhibits Biofilm Formation by Staphylococcus xylosus and Affects Histidine Biosynthesis Pathway Ding, Wenya Zhou, Yonghui Qu, Qianwei Cui, Wenqiang God’spower, Bello Onaghise Liu, Yanyan Chen, Xueying Chen, Mo Yang, Yanbei Li, Yanhua Front Pharmacol Pharmacology Staphylococcus xylosus, a coagulase-negative, non-pathogenic bacterium, responsible for opportunistic infections in humans and bovine mastitis, has the ability to form biofilms, which are responsible for persistent infections and antibiotic resistance. In our study, azithromycin significantly inhibited biofilm formation by altering protein expression. Of the 1764 proteins measured by the isobaric Tag for Relative and Absolute Quantification (iTRAQ) technique, only 148 proteins showed significantly different expression between the azithromycin-treated and untreated cells. Most ribosomal proteins were markedly up-regulated, and the expression of the proteins involved in histidine biosynthesis, which, in turn, influence biofilm formation, was down-regulated, particularly imidazole glycerophosphate dehydratase (IGPD). Previously, we had observed that IGPD plays an important role in biofilm formation by S. xylosus. Therefore, hisB expression was studied by real-time PCR, and the interactions between azithromycin and IGPD were predicted by molecular docking analysis. hisB was found to be significantly down-regulated, and six bond interactions were observed between azithromycin and IGPD. Many active atoms of azithromycin did not interact with the biologically active site of IGPD. Surface plasmon resonance analysis used to further study the relationship between IGPD and azithromycin showed minimum interaction between them. Histidine content in the azithromycin-treated and untreated groups was determined. We noted a slight difference, which was not consistent with the expression of the proteins involved in histidine biosynthesis. Therefore, histidine degradation into glutamate was also studied, and we found that all proteins were down-regulated. This could be the reason why histidine content showed little change between the treated and untreated groups. In summary, we found that azithromycin is a potential inhibitor of S. xylosus biofilm formation, and the underlying mechanism was preliminarily elucidated in this study. Frontiers Media S.A. 2018-07-10 /pmc/articles/PMC6048454/ /pubmed/30042679 http://dx.doi.org/10.3389/fphar.2018.00740 Text en Copyright © 2018 Ding, Zhou, Qu, Cui, God’spower, Liu, Chen, Chen, Yang and Li. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Ding, Wenya Zhou, Yonghui Qu, Qianwei Cui, Wenqiang God’spower, Bello Onaghise Liu, Yanyan Chen, Xueying Chen, Mo Yang, Yanbei Li, Yanhua Azithromycin Inhibits Biofilm Formation by Staphylococcus xylosus and Affects Histidine Biosynthesis Pathway |
title | Azithromycin Inhibits Biofilm Formation by Staphylococcus xylosus and Affects Histidine Biosynthesis Pathway |
title_full | Azithromycin Inhibits Biofilm Formation by Staphylococcus xylosus and Affects Histidine Biosynthesis Pathway |
title_fullStr | Azithromycin Inhibits Biofilm Formation by Staphylococcus xylosus and Affects Histidine Biosynthesis Pathway |
title_full_unstemmed | Azithromycin Inhibits Biofilm Formation by Staphylococcus xylosus and Affects Histidine Biosynthesis Pathway |
title_short | Azithromycin Inhibits Biofilm Formation by Staphylococcus xylosus and Affects Histidine Biosynthesis Pathway |
title_sort | azithromycin inhibits biofilm formation by staphylococcus xylosus and affects histidine biosynthesis pathway |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048454/ https://www.ncbi.nlm.nih.gov/pubmed/30042679 http://dx.doi.org/10.3389/fphar.2018.00740 |
work_keys_str_mv | AT dingwenya azithromycininhibitsbiofilmformationbystaphylococcusxylosusandaffectshistidinebiosynthesispathway AT zhouyonghui azithromycininhibitsbiofilmformationbystaphylococcusxylosusandaffectshistidinebiosynthesispathway AT quqianwei azithromycininhibitsbiofilmformationbystaphylococcusxylosusandaffectshistidinebiosynthesispathway AT cuiwenqiang azithromycininhibitsbiofilmformationbystaphylococcusxylosusandaffectshistidinebiosynthesispathway AT godspowerbelloonaghise azithromycininhibitsbiofilmformationbystaphylococcusxylosusandaffectshistidinebiosynthesispathway AT liuyanyan azithromycininhibitsbiofilmformationbystaphylococcusxylosusandaffectshistidinebiosynthesispathway AT chenxueying azithromycininhibitsbiofilmformationbystaphylococcusxylosusandaffectshistidinebiosynthesispathway AT chenmo azithromycininhibitsbiofilmformationbystaphylococcusxylosusandaffectshistidinebiosynthesispathway AT yangyanbei azithromycininhibitsbiofilmformationbystaphylococcusxylosusandaffectshistidinebiosynthesispathway AT liyanhua azithromycininhibitsbiofilmformationbystaphylococcusxylosusandaffectshistidinebiosynthesispathway |